Thermal Ablation Vs Thyroidectomy for Large Benign Thyroid Nodules

NCT ID: NCT06607133

Last Updated: 2024-09-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-09-10

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare the safety, efficacy and quality of life between staged thermal ablation and thyroidectomy in the treatment of Large benign thyroid nodules.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Large benign thyroid nodules (BTNs)usually cause compressive symptoms or cosmetic concerns and therefore require treatment. Thyroidectomy remains the mainstay treatment for large, symptomatic BTNs. However, if surgery is not feasible or refused, ablative approach could be considered in selected patients. However, it has been proved that single application of thermal ablation is less effective in causing shrinkage in large thyroid nodules. The possible reason is that it is difficult for single application of thermal ablation to cover all of the nodule tissue in a three-dimension if the nodule is large. In addition, nodule locations adjacent to vital structures might hinder complete treatment in one session because of safety concerns. Few studies reveal that staged thermal ablation (Pre-designed multiple sessions of thermal ablation) can also achieve complete ablation and adequate volume reduction of large benign thyroid nodules. However, there is a lack of comparison between these two methods. Thus, this study is aimed to compare the safety, efficacy, quality of life between staged thermal ablation and thyroidectomy for treating large benign thyroid nodules.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Benign Thyroid Nodules

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

surgery group

patients treated with thyroidectomy for benign thyroid nodules

surgery

Intervention Type PROCEDURE

patients undergo conventional/open thyroidectomy or endoscopic thyroidectomy for large benign thyroid nodules

thermal ablation group

patients treated with staged thermal ablation for benign thyroid nodules

staged thermal ablation

Intervention Type PROCEDURE

patients undergo multiple sessions of thermal ablation for large benign thyroid nodules

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

surgery

patients undergo conventional/open thyroidectomy or endoscopic thyroidectomy for large benign thyroid nodules

Intervention Type PROCEDURE

staged thermal ablation

patients undergo multiple sessions of thermal ablation for large benign thyroid nodules

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* benign thyroid nodules confirmed by surgical pathology in surgery group, and by two separate US-guided fine-needle aspiration (FNA) or core needle biopsy (CNB) in thermal ablation group;
* the largest diameter of the nodule ≥4 cm;
* the presence of nodule-related symptoms, cosmetic concerns, or psychological stress;
* patients treated with surgery, or staged thermal ablation (who explicitly refused surgery);
* more than 12-month follow-up duration

Exclusion Criteria

* suspicion of malignant nodule on ultrasound findings (e.g., marked hypoechoic, microcalcifications, or ill-defined margins);
* comorbidities of other severe diseases;
* without complete treatment and/or follow-up information
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ming-an Yu

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ming-an Yu

Head of the Department of Interventional Medicine

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

China-Japan Friendship Hospital

Beijing, Beijing Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ming-an Yu, MD

Role: CONTACT

86-84205756

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

S2019-283-02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cryoablation of Benign Thyroid Nodules: a Pilot Study
NCT06014229 ACTIVE_NOT_RECRUITING NA